Rare events screening & characterization
We are building a fourth-generation Artificial Intelligence (GEN-IV AI) to empower researchers, startups, and the healthtech industry to advance their understanding of rare events through integrated multi-year risk modeling, uncertainties quantification, and early weak signals characterization.
Research-only • No medical advice
A deeptech platform built for deeptech
From research to impact
Work with scientific partners, clinical teams, and R&D stakeholders through a shared language: assumptions, uncertainty, and evidence trails.
- Shared review workflow with structured artifacts
- Traceable assumptions and uncertainty tags
- Export-ready packs for institutional review
Offer tiers for teams at different stages
Choose the program that best fits your needs and aligns with your deeptech project.
- Core screening workflows (rare-event oriented)
- Audit-ready artifacts and exports
- Collaboration + reviewer notes
- Integrations + custom data flows
- Validation and evaluation support
- Custom pipelines for specialized domains
- Co-design for a targeted pilot
- Bespoke deployment options
- Joint governance and review packs
Ready to build the future of GEN-IV AI ?
Share your use-case, needs and constraints. We will identify the most relevant entry point and illustrate how GEN-IV AI is fundamentally built around trust, ethics, risk assessment, security, full traceability, and regulatory compliance.